Scott Bessent emerging as a contender to succeed Fed's Powell
[NEW YORK] A growing chorus of advisers inside and outside the Trump administration are pushing another name to serve as the next chair of the Federal Reserve: Treasury Secretary Scott Bessent.
President Donald Trump said on Friday (Jun 6) that he would name a successor 'very soon' to replace Jerome Powell, whose term as Fed chair ends in May 2026. The small list of candidates under consideration includes Kevin Warsh, a former Fed official whom Trump interviewed for the Treasury secretary role in November, according to people familiar with the matter.
But Bessent – who is leading Trump's effort to kick-start the US economy with sweeping changes to trade, taxes and regulation – is also now one of the contenders for the job, said the people, who requested anonymity to discuss private conversations. Formal interviews for the position have not begun, two of the people said.
'I have the best job in Washington,' Bessent said in response to a request for comment. 'The president will decide who's best for the economy and the American people.'
A senior administration official, who spoke on the condition of anonymity, disputed the reporting without providing further specifics.
As Treasury chief, Bessent would traditionally play a key role in the search and interview process for the next Fed chair. It's unclear if he would recuse himself as Trump begins to make his decision.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
'Given the amount of trust and confidence that the global financial community has in Scott Bessent, he's an obvious candidate,' said Tim Adams, president and CEO of the Institute of International Finance (IIF). 'He's a dark horse candidate,' Adams said, adding that Warsh – who served as a governor on the Fed board from 2006 to 2011 – would also be a good choice.
Asked specifically about Warsh on Friday, Trump said: 'He's very highly thought of.'
Bessent has been at the forefront of negotiations on a US-China trade deal, arguably the most important of the pacts the president is seeking to forge as part of his effort to reshape the global trade landscape.
'Scott Bessent proved he could implement President Trump's agenda during an incredibly turbulent first six months,' said Steve Bannon, former chief White House strategist and outside adviser to the president. 'He's not just the star of the cabinet, but a safe pair of hands for global capital markets.'
The president, who first nominated Powell to the job in 2017, has regularly complained that the Fed chief has been too reluctant to cut borrowing costs. Trump pushed Powell to lower interest rates in a White House meeting last month.
Powell and Fed officials have held interest rates steady in 2025, arguing a patient approach to policy is appropriate amid economic uncertainty caused by Trump's expanded and evolving use of tariffs. Fed policymakers have said they expect the announced tariffs to weigh on economic growth and boost inflation.
Whoever the Senate confirms for the post will have to prove to the world that the Fed's independence from political meddling remains intact. Trump has said many times that Powell is making a mistake by not lowering rates, and has previously said that he should have a say on rate decisions, raising questions over whether markets would see the next pick as beholden to him.
Bessent or Warsh 'would be given the benefit of the doubt from the financial community' that they would preserve the independence of the Fed's rate-setting authority, IIF's Adams said.
Economist and Trump ally Arthur Laffer said Bessent 'is wonderful, but he already has a job. And his speciality is not monetary policy'.
'As I told the president, I think Kevin Warsh is just perfect for the job,' he said.
Other candidates whose names have previously been floated for Fed chair include Kevin Hassett, the White House's National Economic Council director, Christopher Waller, a Fed governor, and former World Bank president David Malpass. BLOOMBERG
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
33 minutes ago
- Straits Times
Kennedy's new vaccine adviser was expert witness against Merck vaccine
FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. attends a Senate Health, Education, Labor & Pensions Committee hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 14, 2025. REUTERS/Leah Millis One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck's Gardasil vaccine, court records show. Martin Kulldorff, a biostatistician and epidemiologist who publicly criticized COVID-era lockdowns, is one of eight new members named by Kennedy on Wednesday to the Advisory Committee on Immunization Practices, a highly influential panel that recommends which shots should be administered to the American public. Kennedy fired the entire previous 17-member committee of expert vaccine advisers this week, claiming they were "plagued with persistent conflicts of interest" from financial ties to drugmakers. The departing experts say their work was subjected to rigorous vetting and rules for recusal for any conflict. Kulldorff recently served as an expert witness for plaintiffs who accused Merck of concealing the risks of Gardasil, a vaccine for the prevention of cancers caused by human papillomavirus (HPV). In March, a federal judge in North Carolina ruled in favor of Merck in one of those cases that included about 200 lawsuits. At a deposition in October, Kulldorff testified that the plaintiffs paid him $400 an hour and he had already billed for about $33,000 in legal work on the case through late September. He said he also received a $4,000 retainer in the North Carolina case, according to court documents. Kulldorff is also listed as an expert witness in a similar case pending against Merck in Los Angeles state court, records show. Under ACIP's rules, committee members cannot serve as a "paid litigation consultant or expert witness in litigation involving a vaccine manufacturer" during their tenure on the panel. Prior work as an expert witness against drugmakers may require a waiver from the U.S. Centers for Disease Control and Prevention and recusal from votes involving Merck and HPV vaccines. The agency has said in its rules it "will generally consider issuance of waivers in specific situations." Kulldorff and plaintiffs lawyers in the Merck case did not immediately respond to a request for comment. Merck declined to comment. A spokesman for Kennedy's Health and Human Services Department said on Wednesday that "all newly appointed ACIP members were thoroughly vetted." HHS did not immediately respond to a request for comment on Kulldorff. KENNEDY AND GARDASIL Before joining the Trump administration, Kennedy was a longtime plaintiffs' lawyer and played an instrumental role in organizing mass litigation against Merck over its Gardasil vaccine, which brought in sales of $8.58 billion in 2024. The shot is recommended as a routine immunization for 11 and 12-year-olds by the CDC to prevent cervical and certain head and neck cancers caused by the virus. Kennedy's work on the Gardasil case drew attention from Congress during the confirmation process for health secretary. Kennedy said he would divest his financial interest in that litigation to his non-dependent, adult son. In a post on X, Kennedy praised Kulldorff as a "leading expert in vaccine safety and infectious disease surveillance." He also cited his previous service as a government adviser, including on a vaccine safety subgroup assisting the full ACIP board. Kulldorff gained prominence during the COVID-19 pandemic as a co-author of the Great Barrington Declaration in October 2020, which called on public health officials to roll back lockdowns, arguing they were causing irreparable harm. One of his co-authors was Dr. Jay Bhattacharya, who now serves under Kennedy as National Institutes of Health director. Kulldorff wrote a 29-page report on Gardasil that was filed on January 6 in the North Carolina case. His conclusion was that Merck had "not done an appropriate job evaluating potential safety problems" related to the shot. He also highlighted his prior service on ACIP's vaccine safety working groups. Gardasil was approved in the U.S. in 2006 after going through clinical trials to prove its safety and efficacy. "I have served on two CDC ACIP vaccine safety working groups, concerning the measles-mumps-rubella-varicella (MMRV) and COVID vaccines," Kulldorff wrote. He also wrote in his litigation report that he developed some of the methods that are used "by FDA and CDC in their routine post-market vaccine safety surveillance work." REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Straits Times
33 minutes ago
- Straits Times
Abrego Garcia seeks sanctions against Trump administration in wrongful deportation case
FILE PHOTO: Kilmar Abrego Garcia, a Salvadoran migrant who lived in the U.S. legally with a work permit and was erroneously deported to El Salvador, is seen wearing a Chicago Bulls hat, in this handout image obtained by Reuters on April 9, 2025. Abrego Garcia Family/Handout via REUTERS/File photo FILE PHOTO: Jennifer Vasquez Sura, wife of Kilmar Abrego Garcia, a Salvadoran migrant who lived in the U.S. legally with a work permit and was erroneously deported to El Salvador, looks on during a press conference with other family members, supporters and members of the Congressional Hispanic Caucus, in Washington, D.C., U.S., April 9, 2025. REUTERS/Ken Cedeno/File Photo WASHINGTON - Kilmar Abrego Garcia, the man wrongly deported from Maryland to El Salvador before being returned to the United States on migrant smuggling charges, is seeking sanctions against the Trump administration for allegedly stonewalling an inquiry into efforts to secure his return. The case has become a flashpoint over President Donald Trump's hardline immigration policies. Critics have held it up as an example of the administration's willingness to deny due process and evade court orders in its push to deport migrants. Lawyers for Abrego Garcia argued in a court filing late on Wednesday that a judge should punish the federal government for failing to provide meaningful information about steps U.S. agencies took to comply with court orders to facilitate Abrego Garcia's return to the U.S. 'The Government's defiance has not been subtle. It has been vocal and sustained and flagrant,' Abrego Garcia's lawyers wrote in the filing. The filing asked U.S. District Judge Paula Xinis to conclude that the Trump administration did not take all available steps to bring about his return. It also seeks an unspecified sum in fines and to compel U.S. officials to turn over documents they have previously withheld, citing legal privileges. Spokespeople from the U.S. Justice Department and Department of Homeland Security did not immediately respond to requests for comment on the filing. The Trump administration has argued it satisfied court orders by bringing Abrego Garcia to Tennessee last week to face a federal criminal indictment accusing him of transporting migrants living in the U.S. illegally to destinations around the country. Abrego Garcia's lawyers have denounced the charges as 'fantastical' and argued that the indictment should not end a separate lawsuit over his wrongful deportation in March. Abrego Garcia is set to appear for a detention hearing in the criminal case on Friday. The Trump administration has accused Abrego Garcia of being a member of the MS-13 street gang, a charge his lawyers deny. The U.S. Supreme Court ordered the Trump administration to facilitate Abrego Garcia's return after U.S. officials conceded he was mistakenly deported to his native El Salvador despite a prior court order barring him from being returned there. Administration officials initially said they had no way to compel El Salvador to return Abrego Garcia, who had been held in a Salvadorian prison, to U.S. custody. Xinis, who is presiding over the lawsuit, rejected those arguments and in April allowed Abrego Garcia's lawyers to question U.S. officials and seek documents on any steps the Trump administration had taken to secure his return. The Trump administration raised several legal privileges, arguing it did not have to divulge information that could impact U.S. national security or complicate diplomatic negotiations. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
an hour ago
- Business Times
Temasek joins Microsoft, BlackRock and MGX to develop AI infrastructure
[SINGAPORE] Temasek has joined a consortium backed by Microsoft, BlackRock and tech investment company MGX to invest and expand artificial intelligence infrastructure, according to BlackRock's investor day presentation slides on Thursday (Jun 12). The Singapore state investment company has joined AI Infrastructure Partnership, a group that also includes BlackRock's Global Infrastructure Partners, the slides showed. AIP, formed in September with a goal to initially invest more than US$30 billion in AI-related projects, is one of the world's largest efforts to invest in data centres and energy facilities needed to power AI applications such as ChatGPT. It aims to mobilise up to US$100 billion including debt financing for such investments, which will focus on the United States. Temasek's participation comes after the Kuwait Investment Authority joined AIP earlier in June. The sovereign wealth fund of Kuwait was the first non-founder financial anchor investor to join the consortium, which also counts partners including Nvidia and billionaire Elon Musk's xAI. 'Temasek's investment in the AI Infrastructure Partnership reflects our focus on the big shifts and trends of the future,' Ravi Lambah, Temasek's head of strategic initiatives, said in an email to Reuters. 'AI is potentially the most transformative and impactful technology for all sectors and businesses,' he added. Temasek did not disclose financial details of the investment. The global investment company had a net portfolio value of S$389 billion as of March 31, 2024, according to its website. REUTERS